Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide

PHASE3CompletedINTERVENTIONAL

Enrollment

198

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions

Hypertension

Interventions

DRUG

Valsartan plus Hydrochlorothiazide

DRUG

Candesartan plus Hydrochlorothiazide

DRUG

Amlodipine

Trial Locations (2)

Investigative Centers

Novartis Pharmaceuticals, Basel